Kala Pharmaceuticals Inc (KALA) stock has fallen -57.62% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives KALA stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 2. KALA's rank also includes a long-term technical score of 2. The fundamental score for KALA is 95. In addition to the average rating from Wall Street analysts, KALA stock has a mean target price of 19.857. This means analysts expect the stock to add 290.12% over the next 12 months.
What's Happening with KALA Stock Today
Kala Pharmaceuticals Inc (KALA) stock has fallen -6.95% while the S&P 500 is up 1.04% as of 11:36 AM on Thursday, May 13. KALA has fallen -$0.38 from the previous closing price of $5.47 on volume of 1,363,695 shares. Over the past year the S&P 500 has risen 45.58% while KALA has fallen -57.62%. KALA lost -$1.96 per share in the over the last 12 months.